May 15 (Reuters) - Buyout firm Advent International Corp and Shanghai Pharmaceuticals Holding Co are considering making an offer for German drug company Stada Arzneimittel AG , Bloomberg reported on Monday.
Advent and Shanghai Pharmaceuticals are discussing a potential bid of about 70 euros a share, Bloomberg reported, citing people familiar with the matter. (bloom.bg/2pPpTni)
No final decisions have been made and the companies could decide against a bid, the report said.
An offer from the duo could rekindle a bidding war for generic drugmaker Stada.
Rival buyout groups Bain Capital and Cinven have been vying with a consortium comprising Advent and Permira for control of Stada.
Bain and Cinven had offered to buy Stada in April wih an offer of 65.28 euros per share and a dividend of 0.72 euros per Stada share. Their surprisingly large increase on a previous bid valued the company at about 5.3 billion euros ($5.81 billion).
Advent and Stada declined to comment and Reuters was unable to contact Shanghai Pharmaceuticals outside business hours. ($1 = 0.9120 euros)
Reporting by Subrat Patnaik in Bengaluru; Editing by David Goodman